Exicure
XCUR----
Exicure (XCUR)
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated tar...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Exicure Analyst Rating
View MoreForecast & Rating
Aug 16, 2022Price forecast
$10.00468.18%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 day ago, 04:13 AM
Life Beyond the Megacaps: The Complex Reality of 2026's Market Misfits
- Price Alert · Jul 16 at 03:27 AM
Pre-market hot trades in US stocks: Exicure pre-market down 11.09%; AST SpaceMobile pre-market down 11.07%
- benzinga_article · Jul 15 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga_article · Jul 14 at 04:05 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Price Alert · Jul 9 at 11:07 AM
U.S. stock market midday update: Exicure up 15.29% with increased volume, active funds without positive drivers
- StockTitan · Jun 29 at 11:40 PM
Exicure Announces Board and Committee Changes | XCUR Stock News
